Paul M. Chung, MD Radiology - Body Imaging Medicare: Accepting Medicare Assignments Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 |
Dr. Kamron Izadi, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 751 S Weir Canyon Rd Ste 157-180, Anaheim, CA 92808 Phone: 657-427-1901 |
Dr. Thomas Hon-jeh Lee, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 5528 E La Palma Ave, Suite 4-a, Anaheim, CA 92807 Phone: 714-970-0200 Fax: 714-970-0270 |
Lina Duyen Khanh Le, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1111 West La Palma Ave, Anaheim, CA 92801 Phone: 714-999-6080 Fax: 714-999-3924 |
Lawrence I. Harrison, MD Radiology - Body Imaging Medicare: Accepting Medicare Assignments Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 |
Dr. Sayana R Shah, M.D. Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 1211 W La Palma Ave, Suite 100, Anaheim, CA 92801 Phone: 714-956-1686 Fax: 714-956-1725 |
News Archive
The imaging tests used in the diagnosis of possible pulmonary embolism (PE) vary by physician specialty and geographic region, which suggests that some of this imaging may be inappropriate, according to a study in the April issue of the American Journal of Roentgenology (www.ajronline.org).
Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced the presentation of interim results from the first Phase I/II trial of samalizumab, the company's investigational, first-in-class humanized monoclonal antibody.
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are two devastating adult-onset neurodegenerative disorders.
The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute has received a $10 million gift from the Paula and Rodger Riney Foundation to establish the Riney Family Foundation Myeloma Center for Advanced Research Excellence.
Hi-Tech Pharmacal Co., Inc., a specialty pharmaceuticals company, announced today that the US Food and Drug Administration granted final approval for the Company's Abbreviated New Drug Application for levofloxacin ophthalmic solution, 0.5% the generic for Vistakon's Quixin ophthalmic solution, which had sales of $2 million for the 12 months ended December 2010 according to IMS sales data.
› Verified 9 days ago